Opioid Use
525
68
86
291
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
106 trials with published results (20%)
Research Maturity
291 completed trials (55% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.8%
41 terminated out of 525 trials
87.7%
+1.1% vs benchmark
21%
112 trials in Phase 3/4
36%
106 of 291 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 291 completed trials
Clinical Trials (525)
Mindfulness for Pain and Suicide
INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit
Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
Community Driven Substance Use Recovery for High Opioid Overdose Areas
THRIVE: Culturally AdapTed Harm Reduction Intervention
Usual Care Intervention Research Evaluating the Impact of a Personalized Pharmaceutical Plan on the Duration of Opioid Treatment in Non-cancerous Pain
Leveraging Social Networks to Increase COVID-19 Testing Uptake
Neuroimaging of Opioid Phase (OPAL)
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
Opioid Use After Laparoscopic Salpingectomy
Continuous Serratus Anterior Blockade for Sternotomy
Erector Spinae Block Versus Paravertebral Block on Chronic Pain After Mastectomy
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Cannabidiol for Bilateral Total Knee Arthroplasty
Voice Technology to Identify Opioid Use
Understanding the Acute Pain Phenotype in Patients Undergoing Surgery
Medical Cannabis as an Opiate Alternative
Treating Polysubstance Use Using a Novel Digital Technology
"Dexa vs Dexmedetomidine With Bupivacaine in TAP Block for Laparotomy Analgesia
ENDOblock: Bilateral Superficial Cervical Blocks With Local Wound Infiltration in Thyroid Surgery